Laddar...
Molecular and clinical characterization of PARP9 in gliomas: A potential immunotherapeutic target
BACKGROUND: Glioma is a primary malignancy of the central nervous system (CNS). As biomedicine advances, an efficient molecular target is urgently needed for the diagnosis and treatment of glioma. Meanwhile, several studies have demonstrated that glioma development is closely related to immunity. PA...
Sparad:
| I publikationen: | CNS Neurosci Ther |
|---|---|
| Huvudupphovsmän: | , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7366751/ https://ncbi.nlm.nih.gov/pubmed/32678519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13380 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|